The company aims to develop, manage, and exploit intellectual property in the field of biotechnological and pharmaceutical innovations. The main focus of its activities is the development and licensing of proprietary technologies, documentation packages, and platform solutions for research and industrial partners. In addition, the company provides scientific consulting services, technology development, and comprehensive research and development support. This also includes services in process development and technical documentation to enable partners to implement and scale advanced technologies in their own licensed facilities. However, the company itself does not engage in manufacturing or commercial distribution activities. The company may establish branches and subsidiaries both domestically and abroad, participate in other companies both domestically and abroad, and conduct all business that is directly or indirectly related to its purpose. The company may acquire, encumber, dispose of, and manage real estate both domestically and abroad. It may also arrange financing for its own or third-party account and provide securities for the liabilities of affiliated companies.